A Trial of a Single-tablet Regimen of Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Disoproxil Fumarate for the Initial Treatment of Human Immunodeficiency Virus Type 2 Infection in a Resource-limited Setting: 48-Week Results From Senegal, West Africa

Publication | Open Access

DOI Full Paper Access

Citations

References

2018

Year

Selly Ba, Dana N. Raugi, Robert A. Smith, Fatima Sall, Khadim Faye, Stephen E. Hawes, Papa Salif Sow, Moussa Seydi, Geoffrey S. Gottlieb, Fatou Traoré,

Clinical Infectious Diseases

Abstract

References